Literature DB >> 24618262

IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies.

Lætitia Laurent1, Florence Anquetil2, Cyril Clavel2, Ndiémé Ndongo-Thiam3, Géraldine Offer1, Pierre Miossec3, Jean-Louis Pasquali4, Mireille Sebbag1, Guy Serre2.   

Abstract

OBJECTIVES: Anticitrullinated protein antibodies (ACPA) are specifically associated with rheumatoid arthritis (RA) and produced in inflamed synovial membranes where citrullinated fibrin, their antigenic target, is abundant. We showed that immune complexes containing IgG ACPA (ACPA-IC) induce FcγR-mediated tumour necrosis factor (TNF)-α secretion in macrophages. Since IgM rheumatoid factor (RF), an autoantibody directed to the Fc fragment of IgG, is also produced and concentrated in the rheumatoid synovial tissue, we evaluated its influence on macrophage stimulation by ACPA-IC.
METHODS: With monocyte-derived macrophages from more than 40 healthy individuals and different human IgM cryoglobulins with RF activity, using a previously developed human in vitro model, we evaluated the effect of the incorporation of IgM RF into ACPA-IC.
RESULTS: IgM RF induced an important amplification of the TNF-α secretion. This effect was not observed in monocytes and depended on an increase in the number of IgG-engaged FcγR. It extended to the secretion of interleukin (IL)-1β and IL-6, was paralleled by IL-8 secretion and was not associated with overwhelming secretion of IL-10 or IL-1Ra. Moreover, the RF-induced increased proinflammatory bioactivity of the cytokine response to ACPA-IC was confirmed by an enhanced, not entirely TNF-dependent, capacity of the secreted cytokine cocktail to prompt IL-6 secretion by RA synoviocytes.
CONCLUSIONS: By showing that it can greatly enhance the proinflammatory cytokine response induced in macrophages by the RA-specific ACPA-IC, these results highlight a previously undescribed, FcγR-dependent strong proinflammatory potential of IgM RF. They clarify the pathophysiological link between the presence of ACPA and IgM RF, and RA severity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Ant-CCP; Rheumatoid Arthritis; Rheumatoid Factor; Synovitis; TNF-alpha

Mesh:

Substances:

Year:  2014        PMID: 24618262     DOI: 10.1136/annrheumdis-2013-204543

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  46 in total

Review 1.  Arthritis models: usefulness and interpretation.

Authors:  Natacha Bessis; Patrice Decker; Eric Assier; Luca Semerano; Marie-Christophe Boissier
Journal:  Semin Immunopathol       Date:  2017-03-27       Impact factor: 9.623

2.  Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Authors:  Jeremy Sokolove; Catriona A Wagner; Lauren J Lahey; Harlan Sayles; Michael J Duryee; Andreas M Reimold; Gail Kerr; William H Robinson; Grant W Cannon; Geoffrey M Thiele; Ted R Mikuls
Journal:  Rheumatology (Oxford)       Date:  2016-07-31       Impact factor: 7.580

Review 3.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

4.  TNF-β +252 A>G (rs909253) polymorphism is independently associated with presence of autoantibodies in rheumatoid arthritis patients.

Authors:  Fabiano Aparecido de Medeiros; Daniela Frizon Alfieri; Tatiana Mayumi Veiga Iriyoda; Neide Tomimura Costa; Elaine Regina Delicato de Almeida; Marcell Alysson Batisti Lozovoy; Naiara Lourenço Mari; Tamires Flauzino; Edna Maria Vissoci Reiche; Isaias Dichi; Andréa Name Colado Simão
Journal:  Clin Exp Med       Date:  2019-05-02       Impact factor: 3.984

Review 5.  Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.

Authors:  Frits Koning; Ranjeny Thomas; Jamie Rossjohn; Rene E Toes
Journal:  Nat Rev Rheumatol       Date:  2015-05-19       Impact factor: 20.543

6.  Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.

Authors:  Yoichi Nakayama; Ryu Watanabe; Kosaku Murakami; Koichi Murata; Masao Tanaka; Hiromu Ito; Wataru Yamamoto; Kosuke Ebina; Kenichiro Hata; Yuri Hiramatsu; Masaki Katayama; Yonsu Son; Hideki Amuro; Kengo Akashi; Akira Onishi; Ryota Hara; Keiichi Yamamoto; Koichiro Ohmura; Shuichi Matsuda; Akio Morinobu; Motomu Hashimoto
Journal:  Rheumatol Int       Date:  2022-03-10       Impact factor: 2.631

7.  Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.

Authors:  Bingtong Li; Ping Li; Liqi Bi
Journal:  Clin Rheumatol       Date:  2019-11-22       Impact factor: 2.980

8.  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage.

Authors:  Changrong Ge; Dongmei Tong; Bibo Liang; Erik Lönnblom; Nadine Schneider; Cecilia Hagert; Johan Viljanen; Burcu Ayoglu; Roma Stawikowska; Peter Nilsson; Gregg B Fields; Thomas Skogh; Alf Kastbom; Jan Kihlberg; Harald Burkhardt; Doreen Dobritzsch; Rikard Holmdahl
Journal:  JCI Insight       Date:  2017-07-06

9.  A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.

Authors:  Caroline Grönwall; Lisa Liljefors; Holger Bang; Aase H Hensvold; Monika Hansson; Linda Mathsson-Alm; Lena Israelsson; Vijay Joshua; Anna Svärd; Ragnhild Stålesen; Philip J Titcombe; Johanna Steen; Luca Piccoli; Natalia Sherina; Cyril Clavel; Elisabet Svenungsson; Iva Gunnarsson; Saedis Saevarsdottir; Alf Kastbom; Guy Serre; Lars Alfredsson; Vivianne Malmström; Johan Rönnelid; Anca I Catrina; Karin Lundberg; Lars Klareskog
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

Review 10.  Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects.

Authors:  Josef S Smolen; Roberto Caporali; Thomas Doerner; Bruno Fautrel; Fabrizio Benedetti; Burkhard Pieper; Minjun Jang
Journal:  RMD Open       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.